The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -11,966 | -31,598 |
| Prepaid expenses | -4,200 | 300 |
| Accounts payable | -7,357 | 12,164 |
| Accounts payable - related party | 1,817 | 19,450 |
| Accrued expense | 1,891 | -1,226 |
| Net cash used in operating activities | -11,415 | -1,510 |
| Net cash provided by investing activities | - | 0 |
| Notes payable - related party | 12,500 | - |
| Net cash provided by financing activities | 12,500 | 0 |
| Net change in cash | 1,085 | -1,510 |
| Cash and cash equivalents at beginning of period | 2,373 | - |
| Cash and cash equivalents at end of period | 1,948 | - |
Nu-Med Plus, Inc. (NUMD)
Nu-Med Plus, Inc. (NUMD)